News Focus
News Focus
icon url

Truthsocial

05/04/26 12:59 PM

#198398 RE: Musical Shares #198397

And the difficulty of gluestick getting through human trials with out spreading in the body may be a reason fda is slow approval for RDGL human clinical trials.

The expert Dr John Smith will see this across imo. Patience....

Let's go ISOPET and RDGL soon enough imo
icon url

chereb19

05/04/26 1:53 PM

#198402 RE: Musical Shares #198397

I asked a bunch of LLM's if your message was actually truthful.

ChatGPT says: Most of it is inference dressed up as certainty. The core claim—“if it were revolutionary it would already be developed”—is not a reliable test of truth. Medical technologies often take decades, stall, restart, or fail to attract funding for reasons unrelated to efficacy. That timeline alone doesn’t prove anything.

Grok says: This is classic hindsight logic. Take a messy history, compress it into a neat story, and call it “reality.” The leap from “wasn’t picked up by big pharma” to “therefore it’s worthless” is just speculation, not evidence.

Claude says: The argument relies on assumptions about how innovation should progress. In practice, licensing decisions, funding constraints, and regulatory hurdles all influence development paths. These factors cannot be used on their own to determine the validity of a technology.

Copilot says: The message combines selected facts with broad conclusions. While some timeline elements may be accurate, the conclusions drawn from them—particularly about effectiveness or legitimacy—are not supported by evidence.
icon url

Wallstreeter$$$

05/04/26 2:32 PM

#198403 RE: Musical Shares #198397

What qualifies you to contradict what the company and Smith put out exactly? Seems to me posting bs abt Vivos is just a hobby for you guys. Might I suggest getting a real job or even taking up knitting maybe?